NEW SERVICE
Join our new priority response service
INSIGHT ARTICLE
Complex regulatory challenges for lab grown ingredients
New QP loyalty scheme launched
Quality
Sustainability
Diversity & Inclusion
Community
Awards
Current vacancies
Early careers
Contact Us
Insights & resources
Foreign body contamination in pharmaceutical products can pose a major threat to patient health and can have severe consequences. For example, discarding entire product batches and extending production line down time during root cause investigation can result in costly delays.
Working to GMP standards, RSSL’s state-of-the-art laboratories and experienced team of scientists can identify foreign materials in pharmaceutical raw materials, process intermediates and finished products. Crucially, we can analyse foreign matter in the whole range of pharmaceutical matrices, including powders, tablets, capsules and creams, using a range of specialised techniques.
Metal
Metal fragments, dusts and corrosion
Machinery wear debris, greases and oils
Glass
Glass or mineral fragments
Defects in vials/needle strikes
Fibres and hairs
Bone
Subvisible particulates
Precipitates
Hazes
Plant matter
Tablet discolouration
Packaging materials
Films, laminates and foil
Insect fragments
Large volumes of samples for analysis Filter blockages and particles on filters
Nanoparticles
By analysing examples of the typical materials that might come into contact with your drug product or raw materials during manufacture, we create a searchable reference library. In the event of foreign body complaints, this library can be used to assist with root cause investigations.
We offer a comprehensive range of analytical techniques to support in the identification of foreign body contamination, including:
Switchboard: +44 (0)118 918 4000
Customer Services: +44 (0)118 918 4076
We value your trust when sharing your personal data with us. We always treat your data in a fair and respectful manner limited to the purpose above mentioned. If you would like to know more about how we handle your data, please read our privacy notice.